Peter Brooks, MD
Adult Reconstructive Orthopaedic Surgery · Vero Beach, FLNPI 1073558037
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.8%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 90.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $34,632 and has fallen 87.1% since, to $4,467 in 2025.
Across 108 payments — averaging $987.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$96K
- Zimmer Biomet$10K
- Exactech, Inc.$128
- Medacta USA, Inc.$103
- Stryker$75
- Innovation Technologies Inc$55
What the payments were for
- Royalty or licence$21,00020%
- Consulting fees$34,31932%
- Speaking & faculty fees$46,74444%
- Travel & lodging$2,8933%
- Food & beverage$1,6542%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 85 | $96,276 |
| Zimmer Biomet | 18 | $9,973 |
| Exactech, Inc. | 1 | $128 |
| Medacta USA, Inc. | 1 | $103 |
| Stryker | 2 | $75 |
| Innovation Technologies Inc | 1 | $55 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$74,158
- BIRMINGHAM HIP$53,121
- REAL INTELLIGENCE$22,838
- Birmingham Hip Resurfacing$18,908
- Knees Product Portfolio$6,938
- POLAR3$3,675
- POLARSTEM$3,675
- REDAPT$3,675
- LEGION TKS$3,675
- Knees-None$1,500
- Oxford$747
- Persona$497
- ALTEON$128
- TRULIANT$128
- QUADRA$103
How this compares
$106,610 in reported general payments places this provider in the 80th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.
See all adult reconstructive orthopaedic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 43 | $257 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Vero Beach
- Jason StackVero Beach$15K
- Alfredo ArrojasVero Beach$10K
- Carlos LaverniaMiami$5.4M
- Juan SuarezMiami$3.9M
- John RedmondJacksonville$987K
- Gavan DuffyJacksonville$543K
- Timothy van de LeurSummerfield$511K
- Edward StolarskiSarasota$445K
- Andrew NoblePalm Beach Gardens$308K
- Raul GostheMiami$252K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.